These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 1233383)

  • 21. Platelet monoamine oxidase and clinical phenomenology of schizophrenia.
    Baron M; Gruen R; Levitt M; Kane J
    Psychiatry Res; 1984 Mar; 11(3):205-9. PubMed ID: 6587413
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Platelet monoamine oxidase activity in subgroups of alcoholics and controls: results from the Collaborative Study on the Genetics of Alcoholism.
    Anthenelli RM; Tipp J; Li TK; Magnes L; Schuckit MA; Rice J; Daw W; Nurnberger JI
    Alcohol Clin Exp Res; 1998 May; 22(3):598-604. PubMed ID: 9622437
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differences in platelet monoamine oxidase activity in subgroups of schizophrenic and depressive disorders.
    Orsulak PJ; Schildkraut JJ; Schatzberg AF; Herzog JM
    Biol Psychiatry; 1978 Dec; 13(6):637-47. PubMed ID: 737252
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Platelet monoamine oxidase activity in acute schizophrenia: relationship to symptomatology and neuroleptic medication.
    Owen F; Bourne RC; Crow TJ; Fadhli AA; Johnstone EC
    Br J Psychiatry; 1981 Jul; 139():16-22. PubMed ID: 7296184
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Platelet MAO activity in subtypes of alcoholics and controls in a homogenous population.
    Farren CK; Clare AW; Tipton KF; Dinan TG
    J Psychiatr Res; 1998; 32(1):49-54. PubMed ID: 9694000
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reduction of blood platelet monoamine oxidase activity in schizophrenic patients on phenothiazines.
    Takahashi S; Yamane H; Tani N
    Folia Psychiatr Neurol Jpn; 1975; 29(3):207-14. PubMed ID: 2524
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Platelet monoamine oxidase activity in subgroups of schizophrenic disorders.
    Schildkraut JJ; Orsulak PJ; Schatzberg AF; Herzog JM
    Schizophr Bull; 1980; 6(2):220-5. PubMed ID: 7375853
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Some kinetic parameters of platelet monoamine oxidase in chronic schizophrenia.
    Kobes RD; Potkin SG; Wise CD; Bridge TP; Neckers LM; Wyatt RJ
    Psychiatry Res; 1979 Oct; 1(2):179-85. PubMed ID: 298347
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Platelet monoamine oxidase activity in first-degree relatives of schizophrenic patients.
    Propping P; Friedl W
    Psychopharmacology (Berl); 1979 Nov; 65(3):265-72. PubMed ID: 117498
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of chlorpromazine treatment on monoamine oxidase activity in platelets isolated by the Corash method.
    Sahai S; Arora RC; Meltzer HY
    Psychiatry Res; 1981 Oct; 5(2):111-4. PubMed ID: 6945605
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Platelet monoamine oxidase as a function of nongenetic factors.
    Friedhoff AJ; Miller JC
    Schizophr Bull; 1980; 6(2):314-9. PubMed ID: 6103576
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of neuroleptics on platelet monoamine oxidase activity.
    Ho BT; Smith RC; Kralik P; Allen R; Schoolar J; Khan M; DeJohn C
    Biol Psychiatry; 1982 Aug; 17(8):885-95. PubMed ID: 6126230
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of hemodialysis on monoamine oxidase kinetics in platelets from chronic schizophrenic patients.
    Wahlund LO; Smedby Y; Sääf J; Schulman A; Ross AB; Wetterberg L
    Artif Organs; 1983 Aug; 7(3):334-9. PubMed ID: 6625963
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neuroleptic drug effect on platelet monoamine oxidase and plasma amine oxidase in schizophrenia.
    Baron M; Gruen R; Levitt M; Kane J
    Psychiatry Res; 1982 Oct; 7(2):179-87. PubMed ID: 6128754
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Platelet monoamine oxidase in chronic schizophrenic patients.
    Berger PA; Ginsburg RA; Barchas JD; Murphy DL; Wyatt RJ
    Am J Psychiatry; 1978 Jan; 135(1):95-9. PubMed ID: 618534
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Parents of high risk subjects defined by levels of monoamine oxidase activity.
    Puchall LB; Coursey RD; Buchsbaum MS; Murphy DL
    Schizophr Bull; 1980; 6(2):338-46. PubMed ID: 7375867
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Platelet MAO activity in hallucinating and paranoid schizophrenics: a review and meta-analysis.
    Zureick JL; Meltzer HY
    Biol Psychiatry; 1988 May; 24(1):63-78. PubMed ID: 3285902
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Platelet MAO concentration and molecular activity: II. Comparison of normal and schizophrenic populations.
    Rose RM; Castellani S; Boeringa JA; Malek-Ahmadi P; Lankford DA; Bessman JD; Fritz RR; Denney CB; Denney RM; Abell CW
    Psychiatry Res; 1986 Feb; 17(2):141-51. PubMed ID: 2870529
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Platelet monoamine oxidase activity in schizophrenia: relationship to family history of the illness and neuroleptic treatment.
    Maj M; Ariano MG; Pirozzi R; Salvati A; Kemali D
    J Psychiatr Res; 1984; 18(2):131-7. PubMed ID: 6747911
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Schizophrenia and platelet monoamine oxidase: research strategies.
    Buchsbaum MS; Coursey RD; Murphy DL
    Schizophr Bull; 1980; 6(2):375-84. PubMed ID: 6103578
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.